Clinical trials
Terminated Lymphoproliferative Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| National Cancer Institute (NCI) | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| miRagen Therapeutics, Inc. | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Ariad Pharmaceuticals | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Baylor College of Medicine | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 29 |
| Lymphoma | 17 |
| Lymphoma, Non-Hodgkin | 14 |
| Leukemia | 10 |
| Lymphoma, Large B-Cell, Diffuse | 10 |
| Immune System Diseases | 9 |
| Lymphatic Diseases | 9 |
| Lymphoma, T-Cell, Cutaneous | 8 |
| Myeloproliferative Disorders | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.